Home Data Calendar Blog

HLTH

Tables

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Common Stock Value		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	NA	NA	NA	NA
Earnings Per Share Basic		-0.96	-0.31	-0.55	-0.62	-0.21	-0.45	-0.67	0.02	0.26	140.00	0.14	0.09	-1.18	-0.52
Earnings Per Share Diluted		-0.96	-0.31	-0.55	-0.62	-0.21	-0.45	-0.67	0.02	0.24	0.13	0.14	0.08	-1.18	-0.52

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Revenue From Contract With Customer Excluding Assessed Tax		18.80	17.48	9.90	24.77	146.78	69.59	87.70	179.41	192.51	223.68	137.42	64.50	13.26	4.73
Revenues		18.80	17.48	9.90	24.77	146.78	69.59	87.70	179.41	192.51	223.68	137.42	64.50	13.26	4.73
Operating Costs And Expenses		167.70	82.18	95.29	120.61	185.40	137.00	190.16	176.56	169.12	136.30	72.72	49.74	31.36	13.23
Research And Development Expense		32.25	37.10	36.54	44.73	56.15	42.52	44.00	28.79	21.68	9.08	4.66	7.41	1.92	6.88
General And Administrative Expense		9.87	15.85	14.70	16.94	19.16	25.62	25.41	26.91	23.45	33.08	11.38	11.87	16.48	3.69
Selling And Marketing Expense		6.23	7.05	8.06	11.25	19.31	18.13	16.97	34.17	21.20	5.57	1.53	0.43	0.65	0.02
Operating Income Loss		-148.91	-64.70	-85.39	-95.85	-38.62	-67.41	-102.46	2.85	23.38	87.38	64.71	14.76	-18.09	-8.50
Income Tax Expense Benefit		0.06	4.73	NA	NA	-5.32	-1.05	-3.39	NA	-10.62	30.10	12.05	1.23	NA	NA
Net Income Loss		-148.43	-46.97	-83.86	-94.20	-31.51	-66.30	-99.05	2.80	34.23	19.35	19.81	13.03	-19.54	-8.54

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Assets		339.79	492.29	523.86	608.56	694.58	825.04	914.08	983.77	940.06	921.98	NA	NA	316.33	NA
Liabilities		89.53	103.46	100.68	112.70	118.09	235.08	273.70	258.63	233.31	267.61	NA	NA	241.41	NA
Liabilities And Stockholders Equity		339.79	492.29	523.86	608.56	694.58	825.04	914.08	983.77	940.06	921.98	NA	NA	316.33	NA
Stockholders Equity		250.25	388.83	423.18	495.86	576.49	589.96	640.37	725.14	706.75	654.38	-61.33	-85.27	-101.40	-84.98

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Assets Current		110.36	192.24	212.07	287.00	371.15	521.87	620.13	701.41	670.02	669.53	NA	NA	183.70	NA
Cash And Cash Equivalents At Carrying Value		80.89	111.45	128.55	178.20	241.53	304.65	363.12	426.46	409.87	446.59	246.33	38.94	121.58	49.17
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		81.69	112.25	129.35	179.00	242.33	305.99	364.46	440.30	423.71	458.59	252.33	118.94	129.25	50.85
Accounts Receivable Net Current		1.35	1.32	1.71	9.80	18.75	24.78	54.01	75.83	104.59	90.19	NA	NA	4.17	NA
Inventory Net		14.04	63.55	68.37	82.01	82.21	133.31	139.05	132.57	88.39	70.74	NA	NA	36.84	NA
Inventory Finished Goods		37.82	39.18	41.89	45.06	37.87	74.44	73.67	60.77	46.09	21.22	NA	NA	1.65	NA
Other Assets Current		4.80	5.25	3.33	4.57	12.13	13.44	12.19	9.81	7.45	2.09	NA	NA	1.26	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Amortization Of Intangible Assets		2.30	2.40	1.80	1.60	1.30	1.00	0.80	0.60	0.10	0.20	1.50	0.20	NA	NA
Intangible Assets Net Excluding Goodwill		19.64	21.54	NA	NA	16.87	NA	NA	NA	NA	NA	NA	NA	NA	NA
Finite Lived Intangible Assets Net		19.64	21.54	21.77	19.77	16.87	16.04	10.94	9.24	7.67	3.69	NA	NA	2.04	NA
Other Assets Noncurrent		2.89	3.73	3.80	5.33	6.53	7.58	6.90	5.68	3.87	1.41	NA	NA	0.18	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Liabilities Current		43.47	58.41	57.03	67.46	71.19	175.46	210.03	191.74	166.94	181.63	NA	NA	155.90	NA
Accounts Payable Current		7.71	11.11	11.21	16.64	7.15	32.52	38.35	48.84	37.21	35.15	NA	NA	23.85	NA
Accounts Payable And Accrued Liabilities Current		29.30	39.92	35.92	40.17	52.38	47.10	75.82	39.81	29.50	NA	NA	NA	NA	NA
Other Accrued Liabilities Current		5.53	6.07	6.34	7.89	5.55	3.15	10.84	8.54	6.37	NA	NA	NA	NA	NA
Accrued Income Taxes Current		0.36	2.84	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Contract With Customer Liability Current		0.16	0.62	0.47	0.75	1.57	84.90	85.58	84.63	82.17	76.34	NA	NA	115.75	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Other Liabilities Noncurrent		4.43	2.09	2.00	2.00	2.00	3.83	4.94	6.36	6.36	0.88	NA	NA	4.50	NA
Operating Lease Liability Noncurrent		41.64	42.96	41.66	42.83	44.05	44.23	46.45	47.63	46.46	50.03	NA	NA	10.47	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Stockholders Equity		250.25	388.83	423.18	495.86	576.49	589.96	640.37	725.14	706.75	654.38	-61.33	-85.27	-101.40	-84.98
Common Stock Value		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	NA	NA	NA	NA
Additional Paid In Capital		841.79	831.94	819.31	808.13	794.57	776.53	760.64	746.35	730.77	712.62	NA	NA	9.04	NA
Retained Earnings Accumulated Deficit		-591.54	-443.11	-396.14	-312.27	-218.07	-186.57	-120.27	-21.21	-24.02	-58.25	NA	NA	-110.44	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		10.14	12.69	11.50	14.41	15.78	15.69	16.79	16.04	17.42	19.97	2.57	3.02	2.92	0.14

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Net Cash Provided By Used In Operating Activities		-28.72	-12.54	-42.66	-53.88	-51.70	-39.91	-51.83	31.52	8.85	19.51	-2.70	-35.11	151.90	NA
Net Cash Provided By Used In Investing Activities		-1.83	-3.66	-5.99	-8.32	-10.09	-18.27	-20.62	-14.05	-37.56	-19.27	-27.05	-31.84	-71.14	NA
Net Cash Provided By Used In Financing Activities		-0.01	-0.90	-1.00	-1.13	-1.87	-0.30	-3.39	-0.87	-6.17	206.01	163.14	56.64	-2.36	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Net Cash Provided By Used In Operating Activities		-28.72	-12.54	-42.66	-53.88	-51.70	-39.91	-51.83	31.52	8.85	19.51	-2.70	-35.11	151.90	NA
Net Income Loss		-148.43	-46.97	-83.86	-94.20	-31.51	-66.30	-99.05	2.80	34.23	19.35	19.81	13.03	-19.54	-8.54
Depreciation Depletion And Amortization		18.29	13.57	12.36	12.06	11.95	11.40	10.98	10.61	6.43	11.58	9.62	4.88	1.92	NA
Increase Decrease In Inventories		-20.88	-5.19	-13.34	2.08	-58.85	-3.13	37.06	44.18	17.36	7.76	11.66	14.76	25.36	NA
Share Based Compensation		10.14	12.69	11.50	14.41	15.78	15.69	16.79	16.04	17.42	18.73	3.81	3.02	2.92	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Net Cash Provided By Used In Investing Activities		-1.83	-3.66	-5.99	-8.32	-10.09	-18.27	-20.62	-14.05	-37.56	-19.27	-27.05	-31.84	-71.14	NA
Payments To Acquire Property Plant And Equipment		1.37	1.65	2.24	3.91	7.00	12.40	18.00	12.78	34.21	18.09	26.05	30.49	69.91	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Net Cash Provided By Used In Financing Activities		-0.01	-0.90	-1.00	-1.13	-1.87	-0.30	-3.39	-0.87	-6.17	206.01	163.14	56.64	-2.36	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Revenues		18.80	17.48	9.90	24.77	146.78	69.59	87.70	179.41	192.51	223.68	137.42	64.50	13.26	4.73
Biomedical Advanced Research And Development Authority B A R D A, Grant And Other Revenue		1.40	2.70	2.10	0.10	0.90	2.90	3.30	2.00	1.30	0.90	0.00	0.00	0.00	2.60
Private Sector Customers, Product		16.94	14.34	7.30	24.01	52.22	65.88	80.53	175.84	104.03	94.01	32.39	2.41	4.39	2.13
Public Sector Entities, Product		0.44	0.42	0.29	0.48	93.49	0.78	3.82	1.61	87.25	128.59	105.03	62.09	8.87	0.00
Grant And Other Revenue		1.42	2.72	2.31	0.27	1.08	2.93	3.35	1.96	1.23	1.08	NA	NA	0.00	2.60
Product		17.38	14.76	7.59	24.49	145.70	66.66	84.35	177.45	191.28	222.59	137.42	64.50	13.26	2.13
Service		0.40	0.30	NA	NA	1.60	2.60	NA	NA	NA	NA	NA	NA	NA	NA
Revenue From Contract With Customer Excluding Assessed Tax		18.80	17.48	9.90	24.77	146.78	69.59	87.70	179.41	192.51	223.68	137.42	64.50	13.26	4.73
Biomedical Advanced Research And Development Authority B A R D A, Grant And Other Revenue		1.40	2.70	2.10	0.10	0.90	2.90	3.30	2.00	1.30	0.90	0.00	0.00	0.00	2.60
Private Sector Customers, Product		16.94	14.34	7.30	24.01	52.22	65.88	80.53	175.84	104.03	94.01	32.39	2.41	4.39	2.13
Public Sector Entities, Product		0.44	0.42	0.29	0.48	93.49	0.78	3.82	1.61	87.25	128.59	105.03	62.09	8.87	0.00
Grant And Other Revenue		1.42	2.72	2.31	0.27	1.08	2.93	3.35	1.96	1.23	1.08	NA	NA	0.00	2.60
Product		17.38	14.76	7.59	24.49	145.70	66.66	84.35	177.45	191.28	222.59	137.42	64.50	13.26	2.13
Service		0.40	0.30	NA	NA	1.60	2.60	NA	NA	NA	NA	NA	NA	NA	NA
Non Us		0.50	0.00	NA	NA	1.30	1.80	4.00	3.50	NA	NA	NA	NA	NA	NA

Plots across concepts

Line plots across dimensions of each concept